Quality of antiretroviral drugs analyzed in the drug analysis and research unit during 2000--2003

dc.contributor.author	Abuga, KO
dc.contributor.author	Mwagiru, PM
dc.contributor.author	Thoithi, GN
dc.contributor.author	Nguyo, JM
dc.contributor.author	Ngugi, JK
dc.contributor.author	King'ondu, OK
dc.contributor.author	Mugo, HN
dc.contributor.author	Kibwage, IO
dc.date.accessioned	2013-02-20T08:08:23Z
dc.date.issued	2003
dc.identifier.citation	East and Central African journal of pharmaceutical sciences Vol. 6(2003) 20-23	en
dc.identifier.uri	http://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/10413
dc.description.abstract	During the period 2000-2003 the Drug Analysis and Research Unit received and analyzed 33 samples of antiretroviral drugs. Locally manufactured products accounted for 57.6 % of the samples, while the imported drugs constituted 42.4 %. The drugs consisted of single, double and triple component preparations. They were subjected to the identity, assay and dissolution tests. 30 samples (90.9 %) complied with compedial specifications for these tests, while 3 failed. The results obtained show that manufacture of quality generic antiretroviral drugs is achievable.	en
dc.language.iso	en	en
dc.subject	Antiretroviral,	en
dc.subject	Assay,	en
dc.subject	Dissolution,	en
dc.subject	Nucleoside,	en
dc.subject	reverse-transcriptase inhibitor	en
dc.title	Quality of antiretroviral drugs analyzed in the drug analysis and research unit during 2000--2003	en
dc.type	Article	en